Pre- treatment protein landscape in HER2-negative breast cancer treated with carboplatin in a neoadjuvant chemotherapy setting

被引：0
|
作者：
Dahle, Maria Aanesland
Egeland, Eivind Valen
Prasmickaite, Lina
Lingjaerde, Ole Christian
Russnes, Hege
Garred, Oystein
Smebye, Marianne L.
Skjerven, Helle
Schlichting, Ellen
Naume, Bjorn
Maelandsmo, Gunhild
Engebraaten, Olav
Haugen, Mads H.
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-2170
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2170
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancer
    von Minckwitz, Gunter
    Eidtmann, Holger
    Rezai, Mahdi
    Fasching, Peter A.
    Tesch, Hans
    Eggemann, Holm
    Schrader, Iris
    Kittel, Kornelia
    Hanusch, Claus
    Kreienberg, Rolf
    Solbach, Christine
    Gerber, Bernd
    Jackisch, Christian
    Kunz, Georg
    Blohmer, Jens-Uwe
    Huober, Jens
    Hauschild, Maik
    Fehm, Tanja
    Mueller, Berit Maria
    Denkert, Carsten
    Loibl, Sibylle
    Nekljudova, Valentina
    Untch, Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (04): : 299 - 309
  • [2] Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer
    Madoka Iwase
    Masashi Ando
    Kenjiro Aogi
    Tomoyuki Aruga
    Kenichiro Inoue
    Akihiko Shimomura
    Eriko Tokunaga
    Norikazu Masuda
    Hideko Yamauchi
    Toshinari Yamashita
    Hiroji Iwata
    Breast Cancer Research and Treatment, 2020, 180 : 687 - 694
  • [3] CNA Landscape of HER2-Negative Breast Cancer in Anthracycline-Based Neoadjuvant Chemotherapy Regimens
    Ibragimova, M. K.
    Kravtsova, E. A.
    Tsyganov, M. M.
    V. Litviakov, N.
    ACTA NATURAE, 2023, 15 (03): : 66 - 74
  • [4] Long-term survival analysis of addition of carboplatin to neoadjuvant chemotherapy in HER2-negative breast cancer
    Iwase, Madoka
    Ando, Masashi
    Aogi, Kenjiro
    Aruga, Tomoyuki
    Inoue, Kenichiro
    Shimomura, Akihiko
    Tokunaga, Eriko
    Masuda, Norikazu
    Yamauchi, Hideko
    Yamashita, Toshinari
    Iwata, Hiroji
    BREAST CANCER RESEARCH AND TREATMENT, 2020, 180 (03) : 687 - 694
  • [5] Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer
    Katsuhiko Nakatsukasa
    Hiroshi Koyama
    Yoshimi Oouchi
    Seiichi Imanishi
    Naruhiko Mizuta
    Kouichi Sakaguchi
    Yoshifumi Fujita
    Ikuya Fujiwara
    Tatsuya Kotani
    Takayuki Matsuda
    Kenichirou Fukuda
    Midori Morita
    Sadao Kawakami
    Yayoi Kadotani
    Eiichi Konishi
    Akio Yanagisawa
    Tetsuya Taguchi
    Breast Cancer, 2017, 24 : 63 - 68
  • [6] Docetaxel and cyclophosphamide as neoadjuvant chemotherapy in HER2-negative primary breast cancer
    Nakatsukasa, Katsuhiko
    Koyama, Hiroshi
    Oouchi, Yoshimi
    Imanishi, Seiichi
    Mizuta, Naruhiko
    Sakaguchi, Kouichi
    Fujita, Yoshifumi
    Fujiwara, Ikuya
    Kotani, Tatsuya
    Matsuda, Takayuki
    Fukuda, Kenichirou
    Morita, Midori
    Kawakami, Sadao
    Kadotani, Yayoi
    Konishi, Eiichi
    Yanagisawa, Akio
    Taguchi, Tetsuya
    BREAST CANCER, 2017, 24 (01) : 63 - 68
  • [7] Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers
    Haugen, Mads H.
    Lingjaerde, Ole Christian
    Hedenfalk, Ingrid
    Garred, Oystein
    Borgen, Elin
    Loman, Niklas
    Hatschek, Thomas
    Borresen-Dale, Anne-Lise
    Naume, Bjorn
    Mills, Gordon B.
    Maelandsmo, Gunhild M.
    Engebraaten, Olav
    JCO PRECISION ONCOLOGY, 2021, 5 : 286 - 306
  • [8] Optimal Choice of Neoadjuvant Chemotherapy for HER2-Negative Breast Cancer: Clinical Insights
    Lucas, Mairi W.
    Kelly, Catherine M.
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 2493 - 2506
  • [9] Survival outcomes of neoadjuvant chemotherapy with zoledronic acid for HER2-negative breast cancer
    Ishikawa, Takashi
    Akazawa, Kouhei
    Hasegawa, Yoshie
    Tanino, Hirokazu
    Horiguchi, Jun
    Miura, Daishu
    Hayashi, Mitsuhiro
    Kohno, Norio
    JOURNAL OF SURGICAL RESEARCH, 2017, 220 : 46 - 51
  • [10] The history, present situation, and future directions of neoadjuvant chemotherapy for HER2-negative breast cancer
    Oikawa, Masahiro
    CHINESE CLINICAL ONCOLOGY, 2020, 9 (03)
12345